Corynex® is an innovative platform utilizing gram-positive Corynebacterium glutamicum bacterium for long peptide, VHH, and antibody mimetic production. It greatly simplifies the purification process of complex recombinant proteins and improves your drug development process by reducing production costs and time to market.

Advantages of the Corynex System:

• Endotoxin free and minimal impurities during the manufacturing process, reduces the time needed to produce the bulk drug
• Low cost of goods allows you to minimize production costs
• Highly scalable, which improves the chances of a successful commercial launch
• Successful track record in clinical trials (US FDA)